VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,534,709 | -14.6% | 3,467,156 | 0.0% | 3.00% | -17.7% |
Q2 2023 | $55,647,854 | +106.8% | 3,467,156 | 0.0% | 3.64% | +111.8% |
Q1 2023 | $26,905,131 | -56.3% | 3,467,156 | +9.0% | 1.72% | -52.9% |
Q4 2022 | $61,560,903 | -9.2% | 3,181,442 | 0.0% | 3.65% | -7.4% |
Q3 2022 | $67,797,000 | +56.6% | 3,181,442 | 0.0% | 3.94% | +9.4% |
Q2 2022 | $43,299,000 | -42.1% | 3,181,442 | 0.0% | 3.61% | -36.4% |
Q1 2022 | $74,732,000 | -4.0% | 3,181,442 | +9.1% | 5.67% | +24.7% |
Q4 2021 | $77,883,000 | +54.0% | 2,914,776 | 0.0% | 4.55% | +51.9% |
Q3 2021 | $50,571,000 | +30.8% | 2,914,776 | 0.0% | 3.00% | +34.4% |
Q2 2021 | $38,650,000 | – | 2,914,776 | – | 2.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |